Immunity to SARS-CoV-2

 Saturday, May 7, 2022     12:30 PM – 2:30 PM ET     Oregon Ballroom 201

Immunity to SARS-CoV-2

Chairs

• Emily Hemann, The Ohio State Univ., Col. of Med.
• Paul Thomas, Saint Jude Children’s Res. Hosp.

Speakers

• Abigail Solstad, Ohio State Univ., Endogenous interferon-lambda signaling restricts virus replication and disease severity in a murine model of SARS-CoV-2 infection
• Jodi F. Hedges, Montana State Univ., ADAM-17 protease promotes inflammation and mortality while decreasing viral burden in a COVID-19 mouse model
• Xiao He, Univ. of Utah, A longitudinal study of humoral immune responses to SARS-CoV-2 spike proteins in gamma-interferon-inducible lysosomal thiol reductase deficient mice
• Hejun Liu, Scripps Res. Inst., The human IGHD3-22 encoded motif contributes to broad reactivity of anti-SARS-CoV-2 antibodies
• Jennifer R. Habel, Univ. of Melbourne, at Peter Doherty Inst. for Infection and Immunity, Integrated immune networks in SARS-CoV-2 infected pregnant women reveal differential NK cell and unconventional T cell activation
• Krista L. Newell, SUNY Upstate Med. Univ., Spike BATTLE: Simultaneous evaluation of antigen-specific B and T lymphocytes following natural SARS-CoV-2 infection and subsequent mRNA vaccination
• Alba Grifoni, La Jolla Inst. for Immunology, SARS-CoV-2 vaccination induces T cell memory responses able to cross-recognize ongoing SARS-CoV-2 variants including omicron
• Anastasia Minervina, St. Jude Children’s Res. Hosp., Epitope-specific T cell response to SARS-CoV-2 infection and vaccination